Administering RiaSTAP for Congenital Afibrinogenemia During Liver Transplant.

Administering RiaSTAP for Congenital Afibrinogenemia During Liver Transplant. Exp Clin Transplant. 2018 May 16;: Authors: Giordano C, Johnson C, Lawson J, Rajasekhar A, Thomas E Abstract Liver transplant has occasionally been performed in the presence of congenital afibrinogenemia and has been rarely used to treat it. Historically, to safely manage coagulopathy during transplant, these patients have been administered a combination of fresh frozen plasma and cryoprecipitate. In this case report, we discuss the first reported use of recombinant fibrinogen to treat such a patient and the decision-making process considered to balance the thrombotic and hemorrhagic risks. PMID: 29766777 [PubMed - as supplied by publisher]
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - Category: Transplant Surgery Authors: Tags: Exp Clin Transplant Source Type: research